Back
Editas Medicine Stock Price Chart
Sponsored
EDIT
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
EDIT
Editas Medicine
Last Price:
3.92
Seasonality Move:
2.24%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- The current trend is relatively stagnant and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.79 | Buy |
20-day SMA: | 3.75 | Buy |
50-day SMA: | 4.44 | Sell |
200-day SMA: | 6.62 | Sell |
8-day EMA: | 3.8 | Buy |
20-day EMA: | 3.85 | Buy |
50-day EMA: | 4.27 | Sell |
200-day EMA: | 6.06 | Sell |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 47.5 | Sell |
Chaikin Money Flow: | -2434195 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.61 - 3.97) | Buy |
Bollinger Bands (100): | (4.12 - 5.64) | Sell |
Editas Medicine Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
- Editas Medicine share price is 3.87 while EDIT 8-day simple moving average is 3.79, which is a Buy signal.
- The stock price of EDIT is 3.87 while Editas Medicine 20-day SMA is 3.75, which makes it a Buy.
- Editas Medicine 50-day simple moving average is 4.44 while EDIT share price is 3.87, making it a Sell technically.
- EDIT stock price is 3.87 and Editas Medicine 200-day simple moving average is 6.62, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
40
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a Sell
The current Editas Medicine [EDIT] share price is $3.87. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine Stock Info
Market Cap:
319.18M
Price in USD:
3.87
Share Volume:
2.64M
Editas Medicine 52-Week Range
52-Week High:
11.69
52-Week Low:
3.40
Sell
40
Editas Medicine (EDIT)
is a Sell
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?
The Editas Medicine stock price is 3.87 USD today. -
Will EDIT stock go up or go down?
Editas Medicine> share price is forecast to RISE/FALL based on technical indicators -
Is Editas Medicine overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is overvalued.
Is Editas Medicine Stock a Buy?
- Editas Medicine share price is 3.87 while EDIT 8-day exponential moving average is 3.80, which is a Buy signal.
- The stock price of EDIT is 3.87 while Editas Medicine 20-day EMA is 3.85, which makes it a Buy.
- Editas Medicine 50-day exponential moving average is 4.27 while EDIT share price is 3.87, making it a Sell technically.
- EDIT stock price is 3.87 and Editas Medicine 200-day simple moving average is 6.06, creating a Sell signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
- Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.68 per share, and an increase next year of $0.17 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
- EDIT Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Editas Medicine is a Sell
- Editas Medicine Relative Strength Index (RSI) is 47.5, which suggest Editas Medicine is oversold
- The Bollinger Bands (25) for Editas Medicine is (3.61 - 3.97), which suggest Editas Medicine is a Sell
- The Bollinger Bands (100) for Editas Medicine is (4.12 - 5.64), which suggest Editas Medicine is a Sell
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.